- Home
- TVTX vs ARI Comparison
TVTX vs ARI Comparison
Compare TVTX & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- ARI
- Stock Information
- Founded
- TVTX 2008
- ARI 2009
- Country
- TVTX United States
- ARI United States
- Employees
- TVTX N/A
- ARI N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- ARI Real Estate Investment Trusts
- Sector
- TVTX Health Care
- ARI Real Estate
- Exchange
- TVTX Nasdaq
- ARI Nasdaq
- Market Cap
- TVTX 1.4B
- ARI 1.1B
- IPO Year
- TVTX N/A
- ARI 2009
- Fundamental
- Price
- TVTX $16.48
- ARI $9.93
- Analyst Decision
- TVTX Strong Buy
- ARI Hold
- Analyst Count
- TVTX 16
- ARI 5
- Target Price
- TVTX $33.33
- ARI $9.92
- AVG Volume (30 Days)
- TVTX 1.5M
- ARI 1.4M
- Earning Date
- TVTX 07-31-2025
- ARI 07-29-2025
- Dividend Yield
- TVTX N/A
- ARI 10.05%
- EPS Growth
- TVTX N/A
- ARI N/A
- EPS
- TVTX N/A
- ARI N/A
- Revenue
- TVTX $273,533,000.00
- ARI $276,844,000.00
- Revenue This Year
- TVTX $73.84
- ARI $32.11
- Revenue Next Year
- TVTX $46.72
- ARI $19.41
- P/E Ratio
- TVTX N/A
- ARI N/A
- Revenue Growth
- TVTX 75.65
- ARI 104.64
- 52 Week Low
- TVTX $7.93
- ARI $7.70
- 52 Week High
- TVTX $25.29
- ARI $11.20
- Technical
- Relative Strength Index (RSI)
- TVTX 59.73
- ARI 54.26
- Support Level
- TVTX $14.44
- ARI $9.77
- Resistance Level
- TVTX $16.64
- ARI $10.08
- Average True Range (ATR)
- TVTX 0.61
- ARI 0.16
- MACD
- TVTX 0.31
- ARI 0.01
- Stochastic Oscillator
- TVTX 94.18
- ARI 72.73
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About ARI Apollo Commercial Real Estate Finance Inc
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.